Semaglutide
Product Details
Semaglutide — Research Peptide
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist commonly studied in laboratory settings for its interaction with incretin signaling pathways, metabolic regulation mechanisms, and endocrine communication systems. Structurally designed to mimic endogenous GLP-1 activity, Semaglutide has been investigated for its role in peptide-mediated signaling and receptor activation pathways.
Scientific literature has explored Semaglutide in studies involving GLP-1 receptor signaling, glucose metabolism pathways, energy regulation mechanisms, and metabolic homeostasis research. Additional studies have examined how GLP-1 receptor agonists interact with endocrine signaling systems and peptide-mediated cellular communication processes.
Published research has investigated Semaglutide in laboratory models involving incretin pathway activity, receptor-binding analysis, metabolic signaling, and biochemical communication mechanisms. Research has also explored its role in molecular signaling pathways related to energy balance and endocrine regulation.
This compound is supplied for qualified laboratory research and analytical purposes only.
Product Details
Product Name: Semaglutide
Form: Lyophilized peptide powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place under proper laboratory storage conditions.
Research Areas
This compound may be used in research related to:
- GLP-1 receptor signaling pathway studies
- Incretin and endocrine signaling research
- Metabolic homeostasis and energy regulation investigation
- Peptide-receptor interaction analysis
- Glucose metabolism and biochemical signaling studies
- Cellular communication and molecular pathway research
- Endocrine and metabolic signaling pathway investigation
Research References
- Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine.
- Drucker DJ. “Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.” Cell Metabolism.
- Knudsen LB, Lau J. “The Discovery and Development of Liraglutide and Semaglutide.” Frontiers in Endocrinology.
Important Disclaimer
For research use only. Not for human use. Not for animal use. Not for consumption, injection, ingestion, cosmetic use, medical use, veterinary use, or therapeutic application. This product is not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified professionals in a controlled laboratory setting.
Due to current demand and supply availability, peptide vial cap colors may vary. Cap color is determined by available laboratory packaging materials and does not indicate any difference in product identity, specifications, or quality.
Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.
